To test this, primary mouse BMDCs were obtained using the FLT3L differentiation method [27], which enhances their proficiency in tumor antigen presentation for anti-PD1 responses [28], and then stimulated primary cultures using LPS. The gene discussed is FLT3LG; the disease is neoplasm.